Clinical Trials on Miscellaneous Peripheral Blood Cell Abnormalities in Belgium

Total 867 results

Lymphoma Study Association
Janssen-Cilag International NV

Completed

Study of Bortezomib Combined With ACVBP in Peripheral T-cell Lymphoma

Peripheral T-cell Lymphoma

France, Belgium
Sensome

Recruiting

Impedance Sensor Evaluated in Peripheral Artery Disease for Tissue Detection (SEPARATE)

Peripheral Vascular Disease

Belgium
The Lymphoma Academic Research Organisation

Completed

Study of Brentuximab Vedotin in Patients With R/R PTCL Treated With Gemcitabine

Refractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell Lymphoma

France, Belgium
Philips Clinical & Medical Affairs Global

Completed

Tack Optimized Balloon Angioplasty (TOBA) Study (TOBA)

Peripheral Vascular Disease

Belgium
University Hospital, Ghent

Completed

Aortic Valve Dynamics During Exercise After Valve Sparing Root Replacement Surgery

Aneurysm Aortic Root | Aortic Valve, Bicuspid

Belgium
University Hospital, Ghent
JOTEC Company

Completed

Multicentric, Prospective, Randomized, Comparing Trial Between Bypass of the Femoropoplitea by PTFE and Heparin Bounded PTFE

Peripheral Vascular Diseases

Belgium
KU Leuven

Completed

Observational Feasibility Study of Home-based Training With Therabands in PAD-patients

Intermittent Claudication | Peripheral Artery Disease

Belgium
be Medical

Unknown

Safety and Performance of the Zeus CC Stent for the Treatment of Iliac Occlusive Disease (EAZY)

Peripheral Artery Disease

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Biomechanical Analysis of Arterial Tissue From Patient Suffering From Peripheral Artery Disease in the Lower Limb

Peripheral Arterial Disease

Belgium
University Hospital, Ghent

Completed

Belgian Prospective Multicentre Registry on the Performance of the Smart Stent in the Superficial Femoral Artery According to the New Tasc II-classification

Peripheral Vascular Disease

Belgium
KU Leuven

Completed

Exercise Therapy in Patients With Peripheral Artery Disease: Evaluating the Clinical Effectiveness of Exercise Therapy and Exploring Determinants of Improvement (PROSECO)

Peripheral Arterial Disease

Belgium
be Medical

Completed

Remedy, Biodegradable Peripheral Stent Registry

Peripheral Arterial Disease

Belgium
Universitair Ziekenhuis Brussel

Recruiting

The Role of Natural Killer, Complement and T-lymphocytes in COVID-19 Disease, a Prospective Monocentric Study (TONIC)

Covid19 | Peripheral Blood Mononuclear Cells | Complement Abnormality

Belgium
Abbott Medical Devices

Terminated

The ABSORB BTK (Below The Knee) Clinical Investigation

Atherosclerosis | Peripheral Arterial Occlusive Disease | Peripheral Vascular Disease | Peripheral Artery Disease | Claudication | Critical Limb Ischemia | PAD | PVD | Lower Limb Disease | PAOD

Belgium
ID3 Medical
CyndRx, LLC

Completed

AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial

Peripheral Arterial Disease

Belgium
Spectranetics Corporation

Completed

ModificatiOn and Treatment of stenoseD Calcified inFrainguinal Lesions With Laser atherectomY in a Pilot Study (MODIFY)

Peripheral Arterial Disease

Belgium
Flanders Medical Research Program

Completed

Physician-Initiated Trial Investigating the BeGraft Peripheral Stent Graft System

Peripheral Vascular Disease

Belgium
Centre Hospitalier Universitaire Saint Pierre

Recruiting

Clonidine With Morphine in Patient Controlled Analgesia Pump in Vaso-Occlusive Crisis in Sickle Cell Disease Patient

Sickle Cell Disease | Vaso-occlusive Pain Episode in Sickle Cell Disease

Belgium
Flanders Medical Research Program

Unknown

The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery for the Treatment The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery of Femoropopliteal TASC C&D Lesions (ZILVERPASS)

Peripheral Vascular Disease

Belgium
Hanane EL KENZ

Completed

Transfusion in Sickle Cell Disease: Screening of Sickle Cell Disease Trait in Blood Donors

Sickle Cell Disease | Sickle Cell Trait

Belgium
Francis Corazza

Completed

Monocytic Expression of Heme Oxidase-1 (HO-1) in Sickle Cell Patients and Correlation With the Humoral Immune Response to Vaccine and With Allo-immunization.

Sickle Cell Disease

Belgium
Brugmann University Hospital

Completed

Evaluation of the Hemostatic Potential in Sickle Cell Disease Patients

Sickle Cell Disease

Belgium
Brugmann University Hospital

Completed

Added Value of Speckle Tracking in the Evaluation of Patients With Sickle Cell Disease

Sickle Cell Disease

Belgium
ID3 Medical
CyndRx, LLC

Terminated

The AbsorbaSeal Vascular Closure Device Trial

Peripheral Arterial Disease

Belgium
Flanders Medical Research Program

Completed

Prospective, Non-randomized Multi-center, Controlled Physician-initiated Trial: Rotarex Belgium In-stent Occlusion (ROBINSON)

Peripheral Vascular Disease

Belgium
Queen Fabiola Children's University Hospital

Active, not recruiting

Study of Biological Markers in Children With Sickle Cell Disease

Sickle Cell Disease

Belgium
Brugmann University Hospital

Completed

Survey in a Population of Sickle Cell Disease Patients to Evaluate the Transition Between the Queen Fabiola Children Hospital and the CHU Brugmann Hospital, and the Quality of the Hospital Care Within the CHU Brugmann Hospital.

Sickle Cell Disease

Belgium
Provascular GmbH
William Cook Europe

Completed

Evaluation of Paclitaxel Eluting Stent vs Paclitaxel Eluting Balloon Treating Peripheral Artery Disease of the Femoral Artery

Peripheral Artery Disease

Belgium, Germany
ID3 Medical

Completed

Belgian Trial Evaluating the ClearLumen II Peripheral Thrombectomy System Recanalization of (Sub)Acute Thrombotic Femoropopliteal Occlusions (BELTHROM)

Peripheral Arterial Disease

Belgium
Flanders Medical Research Program

Completed

BeSmooth Study, Investigating the BeSmooth Peripheral Stent System for the Treatment of Iliac Lesions (BeSmooth)

Peripheral Arterial Disease

Belgium
Flanders Medical Research Program

Completed

NanoCross BTK, a Prospective, Non-randomized, Multicenter, Controlled Trial Evaluating the Performance of the NanoCrossTM .014 Balloon Catheter in Infrapopliteal Lesions

Peripheral Arterial Disease

Belgium
Flanders Medical Research Program

Completed

Physician-Initiated Trial Investigating the Efficacy of Endovascular Treatment of Femoropopliteal Arterial Stenotic Disease With the Biotronik Passeo-18 Lux Drug Releasing Balloon and the Biotronik Pulsar-18 Stent (Comparing With 4EVER Trial Results) (BIOLUX 4EVER)

Peripheral Vascular Disease

Belgium
Flanders Medical Research Program

Completed

DURABILITY-200: EverFlex 200mm Long Nitinol Stents in TASC C&D Femoropopliteal Lesions

Intermittent Claudication | Peripheral Vascular Disease | Critical Limb Ischemia

Belgium
Medtronic Endovascular
MEDRAD, Inc.

Completed

Atherectomy Followed by a Drug Coated Balloon to Treat Peripheral Arterial Disease (DEFINITIVE AR)

Peripheral Arterial Disease | Claudication

Belgium
be Medical
Universitaire Ziekenhuizen KU Leuven; Ziekenhuis Oost-Limburg

Completed

Belgian Prospective Multicentre Registry to Evaluate Safety and Performance of the Optimed Stent in the Superficial Femoral Artery (BOSS)

Peripheral Arterial Disease

Belgium
Hanane EL KENZ

Completed

Transfusion in Sickle Cell Disease: Risk Factors for Alloimmunization

Sickle Cell Disease

Belgium
Hanane EL KENZ

Withdrawn

Risk Factors for Allo-immunization in Sickle Cell Disease

Sickle Cell Disease

Belgium
Vascuros Medical Pte Ltd
Novella Clinical

Unknown

The VaSecure BTK Study

Peripheral Arterial Occlusive Disease | Peripheral Vascular Disease | Peripheral Artery Disease

Singapore, Belgium, Germany
Millennium Pharmaceuticals, Inc.

Completed

Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma

Refractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell Lymphoma

United States, France, Italy, Poland, United Kingdom, Belgium, Germany, Spain, Belarus, Israel, Portugal, Bulgaria, Turkey, Canada, New Zealand, Peru, Brazil, Russian Federation, Chile, Puerto Rico, Australia, Austria, Hungary, Nether... and more
Biotronik AG
Biotronik, Inc.

Unknown

Study to Determine the Performance of the Astron and Pulsar-18 Stents in Europe (BIOFLEX-I EU)

Peripheral Vascular Disease | Peripheral Artery Disease

Germany, Belgium, Austria, Switzerland
iVascular S.L.U.
FCRE (Foundation for Cardiovascular Research and Education)

Recruiting

Investigating the Safety and Clinical Performance of Seven iVascular Devices for Endovascular Intervention in the Popliteal and/or Infrapopliteal Arteries (POP-BTK)

Peripheral Arterial Disease Below The Knee

Belgium
Terumo Europe N.V.

Completed

Treatment of Patients With Lesions in the Superficial Femoral and/ or Popliteal Arteries Using Kanshas Paclitaxel-coated Balloon Catheter. (KANSHAS-1)

Peripheral Artery Disease | Femoropopliteal Occlusive Disease

Belgium, Germany
Brugmann University Hospital

Completed

Single-center Prospective Evaluation of Sickle Cell Patient Care in the CHU Brugmann Emergency Department

Sickle Cell Disease

Belgium
Flanders Medical Research Program

Unknown

REFLOW Study, Investigating the Efficacy of the LEGFLOW DCB in TASC C&D Fempop Lesions

Peripheral Arterial Disease

Belgium
Flanders Medical Research Program
Medtronic Neurovascular Clinical Affairs

Completed

DURABILITY+ : a Prospective, Multi-center, Controlled Study With the Everflex+ Stent in SFA Lesions (DURABILITY+)

Peripheral Arterial Disease

Belgium
Flanders Medical Research Program

Completed

GORE VIABAHN® Versus Plain Old Balloon Angioplasty (POBA) for Superficial Femoral Artery (SFA) In-Stent Restenosis (RELINE)

Peripheral Vascular Disease

Belgium, Germany
Duomed

Completed

Endovascular Treatment of Peripheral Artery Disease (PAD)

Peripheral Arterial Disease | Iliac Artery Disease | Femoropopliteal Occlusive Disease | Below-the-knee Obstruction

Belgium
be Medical

Terminated

Endovascular Treatment of Peripheral Artery Disease (PAD)

Peripheral Arterial Disease | Iliac Artery Disease | Femoropopliteal Occlusive Disease | Below-the-knee Obstruction

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Efficacy and Safety of the Mammalian Target of Rapamycin (mTor Rapamycin) Inhibitor in Vascular Malformations (vasca-LM)

Cardiovascular Abnormalities

Belgium
QualiMed Innovative Medizinprodukte GmbH

Not yet recruiting

Safety and Efficacy of the QBX Peripheral Balloon Expandable Stent System in Peripheral Artery Disease (PAD) (QBX-RADAR)

Peripheral Arterial Disease

Belgium

3

Subscribe